Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Philip C, Grunert"'
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
The introduction of anti-tumor necrosis factor antibodies resulted in a considerable expansion of the options available for the treatment of inflammatory bowel disease. Unfortunately, approximately one third of treated patients do not respond to thes
Externí odkaz:
https://doaj.org/article/aa012f0e282540d88ad906b2d5913a45
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 13 (2020)
Background: Physicians can improve their relationships with patients by understanding and meeting patients’ treatment targets, leading to higher adherence to therapy and improved disease prognosis. In the current study, we performed a questionnaire
Externí odkaz:
https://doaj.org/article/c1ab8b0963404636b3e1838dc1867fc8
Autor:
Andreas Stallmach, Arndt Steube, Johannes Stallhofer, Philip C. Grunert, Ute Merkel, Michael Hartmann
Publikováno v:
Die Innere Medizin. 63:1036-1042
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de97b1e08f3e38e7f2f53fe1c1b840d7
https://doi.org/10.1007/s00108-022-01399-5
https://doi.org/10.1007/s00108-022-01399-5
Publikováno v:
Journal of Crohn's & Colitis
Background Vaccination is a promising strategy to protect vulnerable groups like immunocompromised inflammatory bowel disease [IBD] patients from an infection with SARS-CoV-2. These patients may have lower immune responses. Little is known about the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b222aed33f4a452fef87b83daaa4544
https://doi.org/10.1093/ecco-jcc/jjab147
https://doi.org/10.1093/ecco-jcc/jjab147
Autor:
Andreas, Stallmach, Arndt, Steube, Johannes, Stallhofer, Philip C, Grunert, Ute, Merkel, Michael, Hartmann
Publikováno v:
Innere Medizin (Heidelberg, Germany)Literatur. 63(10)
Fecal microbiome transfer (FMT) involving the transfer of the microbiome of healthy stool donors to patients with various diseases has been performed in Germany in clinical studies and individual treatment attempts. There is no doubt that FMT is an e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d32d261684008a87645493855273676b
https://pubmed.ncbi.nlm.nih.gov/36053300
https://pubmed.ncbi.nlm.nih.gov/36053300
Publikováno v:
Zeitschrift für Gastroenterologie. 57:834-842
Although the pathogenesis of ulcerative colitis (UC) remains elusive, substantial progress in understanding its development and progression has been achieved in the past decades, and novel effective treatment strategies have been developed. Changes i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a6381b31e1ec3feaa37f149d20d3cf1
https://doi.org/10.1055/a-0874-6603
https://doi.org/10.1055/a-0874-6603
Autor:
Philip C, Grunert, Axel, Dignass, Torsten, Kucharzik, Andreas, Stallmach, Andreas, Sturm, Carsten, Schmidt
Publikováno v:
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
In order to improve the care of patients with chronic inflammatory bowel diseases during the coronavirus disease 2019 (COVID-19) pandemic, the currently valid guidelines of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5ea43cb1528549c10a5a14b6759afe6e
https://pubmed.ncbi.nlm.nih.gov/33320280
https://pubmed.ncbi.nlm.nih.gov/33320280
Publikováno v:
DGVS Digital: BEST OF DGVS.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5ae031426c2d42f58b1814d40d062c7
https://doi.org/10.1055/s-0040-1716130
https://doi.org/10.1055/s-0040-1716130
Publikováno v:
Journal of Crohn's & Colitis
Journal of Crohns and Colitis
Journal of Crohns and Colitis
Background The coronavirus disease 2019 [COVID-19] pandemic is affecting lives worldwide. The influence of inflammatory bowel disease [IBD] medication and IBD itself on COVID-19 is controversial. Additionally, IBD-focused guidance is scarce. Objectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ace9a128e272a831bfa5c4cb8f131259
http://europepmc.org/articles/PMC7337669
http://europepmc.org/articles/PMC7337669
Publikováno v:
Therapeutic Advances in Gastroenterology
Therapeutic Advances in Gastroenterology, Vol 13 (2020)
Therapeutic Advances in Gastroenterology, Vol 13 (2020)
Background: Physicians can improve their relationships with patients by understanding and meeting patients’ treatment targets, leading to higher adherence to therapy and improved disease prognosis. In the current study, we performed a questionnaire
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b49e9e52f03f4ace2a9189f690afb6f3
https://pubmed.ncbi.nlm.nih.gov/33240395
https://pubmed.ncbi.nlm.nih.gov/33240395